Elizabeth A. Samuels, MD, MPH; Joseph S. Ross, MD, MHS; Sanket S. Dhruva, MD, MHS
Disclaimer: The authors assume full responsibility for the accuracy and completeness of the ideas presented, which do not represent the views of the U.S. Department of Veterans Affairs or any other supporting intuitions.
Financial Support: This project was not supported by any external grants or funds. Dr. Samuels is supported by the National Clinician Scholars Program. Dr. Dhruva is supported by the Robert Wood Johnson Foundation Clinical Scholars Program. Drs. Samuels and Dhruva are supported by the U.S. Department of Veterans Affairs.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-1823.
Reproducible Research Statement:Study protocol and statistical code: Available from Dr. Samuels (e-mail, firstname.lastname@example.org). Data set: Available for purchase from the Centers for Medicare & Medicaid Services (www.cms.gov/Research-Statistics-Data-and-Systems/Files-for-Order/NonIdentifiableDataFiles/PrescriptionDrugPlanFormularyPharmacyNetworkandPricingInformationFiles.html).
Samuels EA, Ross JS, Dhruva SS. Medicare Formulary Coverage Restrictions for Prescription Opioids, 2006 to 2015. Ann Intern Med. ;167:895–896. doi: 10.7326/M17-1823
Download citation file:
Published: Ann Intern Med. 2017;167(12):895-896.
Published at www.annals.org on 10 October 2017
Healthcare Delivery and Policy.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use